Neuronetics (STIM) Retained Earnings (2017 - 2026)
Neuronetics' (STIM) quarterly Retained Earnings came in at -$469.6 million in Q1 2026, down 8.57% year-on-year from -$513.6 million in Q1 2025, and down 2.35% on a QoQ basis from -$458.8 million in Q4 2025.
Neuronetics (STIM) Retained Earnings (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of Retained Earnings data on file, last reported at -$469.6 million in Q1 2026.
- On a quarterly basis, Retained Earnings fell 8.57% year-over-year to -$469.6 million in Q1 2026; TTM through Mar 2026 was -$469.6 million, a 8.57% decrease from a year earlier, with the FY2025 full-year figure at -$458.8 million, down 9.29% from the prior year.
- Retained Earnings for Q1 2026 stood at -$469.6 million, down from -$458.8 million in the prior quarter.
- Over the last five years, Retained Earnings for STIM reached as high as -$319.6 million in Q1 2022 and fell as low as -$469.6 million in Q1 2026.
- Historically, Retained Earnings has averaged -$391.6 million across 5 years, with a median of -$384.0 million in 2024.
- Across the five-year window, Retained Earnings dropped 12.65% in 2022 and decreased 7.74% in 2024, its largest moves.
- Year by year, Retained Earnings stood at -$345.9 million in 2022, then dropped by 8.73% to -$376.1 million in 2023, then dropped by 11.62% to -$419.8 million in 2024, then declined by 9.29% to -$458.8 million in 2025, then fell by 2.35% to -$469.6 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$469.6 million in Q1 2026, -$458.8 million in Q4 2025, and -$451.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.32 Bn |
| 10 | Neuronetics | 130.83 Mn | 128.62 Mn | 16.15 Mn | -469.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -469.58 Mn |
| Dec 31, 2025 | -458.79 Mn |
| Sep 30, 2025 | -451.63 Mn |
| Jun 30, 2025 | -442.58 Mn |
| Mar 31, 2025 | -432.50 Mn |
| Dec 31, 2024 | -419.79 Mn |
| Sep 30, 2024 | -407.13 Mn |
| Jun 30, 2024 | -393.79 Mn |
| Mar 31, 2024 | -384.00 Mn |
| Dec 31, 2023 | -376.08 Mn |
| Sep 30, 2023 | -370.70 Mn |
| Jun 30, 2023 | -361.31 Mn |
| Mar 31, 2023 | -356.40 Mn |
| Dec 31, 2022 | -345.89 Mn |
| Sep 30, 2022 | -337.60 Mn |
| Jun 30, 2022 | -329.99 Mn |
| Mar 31, 2022 | -319.57 Mn |
| Dec 31, 2021 | -308.73 Mn |
| Sep 30, 2021 | -301.10 Mn |
| Jun 30, 2021 | -292.95 Mn |